Eli Lilly and Company
SELECTIVE ESTROGEN RECEPTOR DEGRADERS
Last updated:
Abstract:
Novel selective estrogen receptor degraders (SERDs) according to the formula: ##STR00001## pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein either R.sup.1 or R.sup.2 is independently selected from Cl, F, --CF.sub.3, or --CH.sub.3, and the other is hydrogen, and methods for their use are provided.
Status:
Application
Type:
Utility
Filling date:
11 Jul 2019
Issue date:
16 Jan 2020